Is Gilead Sciences Stock Outperforming the S&P 500?
What it means
- What to watch: Healthcare upside usually comes in discrete events — readouts, approvals and launches — rather than gradual trends.
- How the stocks are trading: $GILD +6.19%, $^GSPC -0.30% in the latest session.
- Timing: It landed before the opening bell — early risers had it with their coffee, and the next session was the first that could react.
Where the stock stands
$GILD last changed hands at $169.05, +6.19% on the session, -2.0% below its 52-week high of $165.70 and 48% above its low of $114.02 — within a tenth of its 52-week high. Over the year it has ranged 45% from low to high: a moderate band — lively, not wild. $^GSPC last changed hands at $7,720.39, -0.30% on the session, 1.6% below its 52-week high of $7,844.52 and 22% above its low of $6,316.91 — within a tenth of its 52-week high. Over the year it has ranged 24% from low to high: a moderate band — it moves, but it rarely makes a scene. These are latest-session quotes, not live prices.
How much coverage it is getting
In the last 30 days Wook has filed 119 stories about these names — 33 of them this week. At its 30-day pace you would expect about 28 a week, so this week is about normal — and for this name, busy is the resting state. Across those stories the wording ran 40% bullish, 50% neutral and 10% bearish. This one reads bullish, so it sits with a sizeable part of the run — it has company, but it is not the consensus. 12 related stories — same name or same desk — are lined up beside this one if you want the whole thread.
The bigger picture
In healthcare, the calendar is the catalyst — trial readouts, FDA decisions and pricing rules. One result can move a single drugmaker sharply; a policy change moves the whole aisle. On Wook's supply-chain scanner, Health Care reads calm today — no unusual stress in the filings and disclosures it watches. The scanner equivalent of a quiet night shift.
Coming up
$GILD earnings today. These were on the calendar before this story and are not caused by it, but the nearest is close enough that the hard numbers get the last word soon.
What to watch next
The $GILD page has the full chart, the filings and the valuation model behind every figure here. Want the facts without the spin? Read how two or three outlets frame the same story — where they agree is the news, where they differ is the angle. Wook AI, above, can pull live figures and run the numbers on request — how far $GILD is from its high, or how this week's coverage compares.
How this analysis was made
Yahoo Finance published it, and Wook filed it under Healthcare & Pharma. It reads bullish at medium severity because of “outperform” in the wording, with nothing on the bearish side to offset it. It was matched to $GILD and $^GSPC; a company mentioned in passing is tagged the same as the subject, so check which one the story is really about. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Yahoo Finance published this on September 3, 2026. $GILD has moved +11.79% ($151.22 to $169.05) and $^GSPC has moved -0.35% ($7747.71 to $7720.39). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.